This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a Université de Moncton directory, so their courses may be missing. Find their university profile.
Research
Latest papers
Targeting in vitro vasculogenic mimicry and associated stemness transcriptional signature in human ovarian cancer cell models: new emerging roles of caffeic acid phenethyl ester synthetic analogs.
Frontiers in pharmacology · 2026 · first author
Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles.
Biochemical pharmacology · 2025
Structure-Photoprotective Capacity Relationship of Phenolic Hydroxyl, Methoxy, and Ethenyl Linker Moieties of Phenolic Acids.
Chemistry & biodiversity · 2025 · senior author
Latest funding
- $72,000
Exploring the molecular diversity of phenolic acids and polyphenols to advance the knowledge for the development of new biologically-active molecules
NSERC · 2022 · Principal investigator
- $30,000
New phenolic acid analogs as fatty acid metabolism inhibitors
NSERC · 2019 · Principal investigator
- $150,000
Design and synthesis of phenolic acid analogues as inhibitors of fatty acid metabolism
NSERC · 2014 · Principal investigator
63 publications.
Targeting in vitro vasculogenic mimicry and associated stemness transcriptional signature in human ovarian cancer cell models: new emerging roles of caffeic acid phenethyl ester synthetic analogs.
Touaibia M, Boudah A, Zgheib A, Danalache BA, Annabi B
Defining the role of 12-lipoxygenase in regulating platelet-derived extracellular vesicles.
Matthew AJ, Richard JD, Gauvin VL, Hébert MPA, Touaibia M, Allain EP, Boudreau LH
Structure-Photoprotective Capacity Relationship of Phenolic Hydroxyl, Methoxy, and Ethenyl Linker Moieties of Phenolic Acids.
Ghazi S, Tavakoli H, Omakele E, Martin LJ, Touaibia M
The Activation of the CCND1 Promoter by AP-1 and SOX Transcription Factors in PC3 Prostate Cancer Cells Can Be Prevented by Anacardic Acid Analogs.
Brunie M, Robichaud MA, Touaibia M, Martin LJ
Novel Oxadiazole-Based Bioisostere of Caffeic Acid Phenethyl Ester: Synthesis, Anticancer Activity, and Inhibition of Lipoxygenase Product Biosynthesis.
Robichaud MA, Chiasson AI, Doiron JA, Hébert MPA, Surette ME, Touaibia M
Anti-Cancer Potential of a new Derivative of Caffeic Acid Phenethyl Ester targeting the Centrosome.
Giordano C, Kendler J, Sexl M, Kollman S, Varenicja M, Szabó B, Timelthaler G, Kirchhofer D, Hollóczki O, Turner SD, Moriggl R, Kenner L, Touaibia M, Merkel O
Prevention of Male Late-Onset Hypogonadism by Natural Polyphenolic Antioxidants.
Martin LJ, Touaibia M
Single and multiple inhibitors of the biosynthesis of 5-, 12-, 15-lipoxygenase products derived from cinnamyl-3,4-dihydroxy-α-cyanocinnamate: Synthesis and structure-activity relationship.
Touaibia M, Chiasson AI, Robichaud S, Doiron JA, Hébert MPA, Surette ME
Effects of Red Sorghum-Derived Deoxyanthocyanidins and Their O-β-D-Glucosides on E-Cadherin Promoter Activity in PC-3 Prostate Cancer Cells.
Mora N, Rosa M, Touaibia M, Martin LJ
Algerian Propolis from Distinct Geographical Locations: Chemical Profiles, Antioxidant Capacity, Cytotoxicity and Inhibition of 5-Lipoxygenase Product Biosynthesis.
Ayad AS, Hébert MPA, Doiron JA, Loucif-Ayad W, Daas T, Smagghe G, Alburaki M, Barnett DA, Touaibia M, Surette ME
Exploring the molecular diversity of phenolic acids and polyphenols to advance the knowledge for the development of new biologically-active molecules
Principal investigators: Touaibia, Mohamed
Keywords: medicinal chemistry; organic synthesis; phenolic acids; polyphenols; natural products; molecular docking; inflammation; cancer
New phenolic acid analogs as fatty acid metabolism inhibitors
Principal investigators: Touaibia, Mohamed
Design and synthesis of phenolic acid analogues as inhibitors of fatty acid metabolism
Principal investigators: Touaibia, Mohamed
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Mohamed Touaibia and Nicolas Pichaud: 7 shared papers
- Mohamed Touaibia and Pier Morin: 7 shared papers
- Etienne Hebert-Chatelain and Nicolas Pichaud: 6 shared papers
- Sandra Turcotte and Mohamed Touaibia: 3 shared papers
- Miroslava Cuperlovic-Culf and Mohamed Touaibia: 3 shared papers
- Etienne Hebert-Chatelain and Mohamed Touaibia: 2 shared papers
- THOMAS PULINILKUNNIL and Mohamed Touaibia: 2 shared papers
- Nicolas Pichaud and Pier Morin: 2 shared papers
- Sandra Turcotte and Miroslava Cuperlovic-Culf: 1 shared paper
- Sandra Turcotte and THOMAS PULINILKUNNIL: 1 shared paper
- Tony Reiman and THOMAS PULINILKUNNIL: 1 shared paper
- Tony Reiman and Mohamed Touaibia: 1 shared paper
- Mohamed Touaibia and Vett Lloyd: 1 shared paper
- Chemistry and Biochemistry
- Chimie et biochimie
- Département de Chimie et Biochimie
- Biochemistry, Microbiology & Immunology
- Biologie
- Biochemistry and Molecular Biology
- Oncology
- Other
Co-authors at Université de Moncton, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Pier Morin
Chemistry and Biochemistry
7 shared papers, latest 2017
Nicolas Pichaud
Département de Chimie et Biochimie
7 shared papers, latest 2023
Sandra Turcotte
Chemistry and Biochemistry
3 shared papers, latest 2022
Miroslava Cuperlovic-Culf
Biochemistry, Microbiology & Immunology
3 shared papers, latest 2022
Etienne Hebert-Chatelain
Biologie
2 shared papers, latest 2020
THOMAS PULINILKUNNIL
Biochemistry and Molecular Biology
2 shared papers, latest 2018
Vett Lloyd
Biology
1 shared papers, latest 2014
Tony Reiman
Oncology
1 shared papers, latest 2020
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.